COMMUNIQUÉS West-GlobeNewswire

-
Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
12/03/2024 -
Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock
12/03/2024 -
Assure Holdings Enters into Agreement to Sell Certain of its Assets to MPOWERHealth
11/03/2024 -
Foundation Health Secures $6 Million in Seed Funding to Power the Next Generation of Consumer Healthcare Experiences
11/03/2024 -
Appointment of Dr Darren Patti to Group Chief Operating Officer
11/03/2024 -
Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
11/03/2024 -
BioRestorative Therapies to Participate in the 36th Annual ROTH Conference
11/03/2024 -
CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update
11/03/2024 -
Eupraxia Pharmaceuticals Announces Overnight Marketed Offering of Approximately $30 Million
11/03/2024 -
Cognition Therapeutics Announces Proposed Public Offering of Common Stock
11/03/2024 -
Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
11/03/2024 -
Larimar Therapeutics Announces the Dosing of the First Patient in Long-term Open Label Extension Study for Nomlabofusp in Patients with Friedreich’s Ataxia
11/03/2024 -
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2023 Results
11/03/2024 -
NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results
11/03/2024 -
LifeMD Reports Fourth Quarter 2023 Results
11/03/2024 -
Crinetics Pharmaceuticals Announces March 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/03/2024 -
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
11/03/2024 -
SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024
11/03/2024 -
Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
11/03/2024
Pages